SnapPath 1000 Biomarker Testing System
The SnapPath 1000 biomarker testing system is an automated live tumor cell-processing instrument that enables predictive diagnostics. SnapPath data helps medical oncologists determine the best treatment options for individual cancer patients. Manufactured by BioMarker Strategies (Baltimore, MD). Entry submitted by HS Design Inc. (Gladstone, NJ). Supply and design credit to HS Design Inc., Sparton Medical Systems (Strongsville, OH), and Mack Molding (Arlington, VT).